BioPharm International | Maximum Output Starts with Optimized Upstream Processing
MAXIMUM OUTPUT STARTS WITH OPTIMIZED UPSTREAM PROCESSING
Read More
KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina
KBI BIOPHARMA EXPANDS US OPERATIONS WITH NEW $150 MILLION COMMERCIAL MANUFACTURING FACILITY BASED IN RTP, NORTH CAROLINA
JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities For Selexis And KBI Biopharma In Geneva, Switzerland
JSR LIFE SCIENCES EXPANDS ITS EUROPEAN GENE-TO-GMP BIOLOGICS MANUFACTURING FACILITIES FOR SELEXIS AND KBI BIOPHARMA IN GENEVA, SWITZERLAND
AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma
ABSCI CLOSES $15.4 M IN SERIES D FUNDING TO ACCELERATE GROWTH AND SCALE DISRUPTIVE PROTEIN PRINTINGTM TECHNOLOGY, ANNOUNCES EXCLUSIVE CO-MARKETING...
Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform
ZyVersa Therapeutics to Advance Development of it's Lead Inflammasome Inhibitor with Selexis and KBI Biopharma's Integrated Development Platform
Press Release | KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board
KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board Industry Experts to Provide Strategic Guidance as the Companies Advance...
Press Release | CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles
CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles Implementing scalable manufacturing...
KBI in the News | KBI boosts analytical services with Belgium expansion - via BioProcess International
KBI in the News | KBI boosts analytical services with Belgium expansion - via BioProcess International
KBI in the News | AdAlta secures key manufacturing agreements for AD-214
KBI in the News | AdAlta secures key manufacturing agreements for AD-214
Press Release | KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market
KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market